These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 34849300)

  • 1. The feasibility and safety of "one-stop" left atrial appendage closure and percutaneous coronary intervention in atrial fibrillation patients with significant coronary artery disease (PCI-LAAC study).
    Wang Y; Wu D; Ma J; Liu X; Zhang H; So CY; Lam YY; Wang B; Wang J; Zhang H; Wang M; Song G; Wu Y
    Am J Cardiovasc Dis; 2021; 11(5):679-687. PubMed ID: 34849300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Left Atrial Appendage Closure Versus Direct Oral Anticoagulants in High-Risk Patients With Atrial Fibrillation.
    Osmancik P; Herman D; Neuzil P; Hala P; Taborsky M; Kala P; Poloczek M; Stasek J; Haman L; Branny M; Chovancik J; Cervinka P; Holy J; Kovarnik T; Zemanek D; Havranek S; Vancura V; Opatrny J; Peichl P; Tousek P; Lekesova V; Jarkovsky J; Novackova M; Benesova K; Widimsky P; Reddy VY;
    J Am Coll Cardiol; 2020 Jun; 75(25):3122-3135. PubMed ID: 32586585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Left atrial appendage closure in nonvalvular atrial fibrillation patients with percutaneous coronary intervention.
    Yu Y; Xu J; Wang L; Ye Z; Chen Z; Chen F
    BMC Cardiovasc Disord; 2022 Oct; 22(1):433. PubMed ID: 36192682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of combined catheter ablation and left atrial appendage closure for symptomatic atrial fibrillation in patients with high stroke and bleeding risk.
    Kawakami H; Nolan MT; Phillips K; Scuffham PA; Marwick TH
    Am Heart J; 2021 Jan; 231():110-120. PubMed ID: 32822655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and Efficacy of Left Atrial Appendage Closure with the Amplatzer Cardiac Plug in Very High Stroke and Bleeding Risk Patients with Non-Valvular Atrial Fibrillation.
    Kebernik J; Jose J; Abdel-Wahab M; Stöcker B; Geist V; Richardt G
    Cardiol Ther; 2015 Dec; 4(2):167-77. PubMed ID: 26563411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and feasibility of atrial fibrillation ablation after left atrial appendage closure: A single-center experience of the left atrial appendage closure first strategy.
    Chatani R; Kubo S; Tasaka H; Sakata A; Yoshino M; Maruo T; Kadota K
    J Arrhythm; 2024 Aug; 40(4):879-890. PubMed ID: 39139871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-Effectiveness of Left Atrial Appendage Closure for Stroke Prevention in Atrial Fibrillation Patients With Contraindications to Anticoagulation.
    Saw J; Bennell MC; Singh SM; Wijeysundera HC
    Can J Cardiol; 2016 Nov; 32(11):1355.e9-1355.e14. PubMed ID: 27432692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. One-stop strategy for treatment of atrial fibrillation: feasibility and safety of combining catheter ablation and left atrial appendage closure in a single procedure.
    Chen M; Wang ZQ; Wang QS; Sun J; Zhang PP; Feng XF; Li W; Yu Y; Liu B; Mo BF; Zhang R; Yang M; Gong CQ; Zhao MZ; Yu YC; Zhao Y; Lu QF; Li YG
    Chin Med J (Engl); 2020 Jun; 133(12):1422-1428. PubMed ID: 32433041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual antiplatelet therapy is safe and efficient after left atrial appendage closure.
    Maksym J; Mazurek T; Kochman J; Grygier M; Kapłon-Cieślicka A; Marchel M; Lodziński P; Piątkowski R; Wilimski R; Czub P; Fojt A; Karolczak N; Hendzel P; Opolski G
    Kardiol Pol; 2018; 76(2):459-463. PubMed ID: 29350390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous left atrial appendage closure followed by single antiplatelet therapy: Short- and mid-term outcomes.
    Jalal Z; Dinet ML; Combes N; Pillois X; Renou P; Sibon I; Iriart X; Thambo JB
    Arch Cardiovasc Dis; 2017 Apr; 110(4):242-249. PubMed ID: 28065447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Left atrial appendage closure in atrial fibrillation patients with prior major bleeding or ineligible for oral anticoagulation.
    Wintgens LIS; Vorselaars VMM; Klaver MN; Swaans MJ; Alipour A; Rensing BJWM; Post MC; Boersma LVA
    Neth Heart J; 2019 Dec; 27(12):613-620. PubMed ID: 31187455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Midterm follow-up after computed tomography angiography planned left atrial appendage closure.
    Rana MA; Yoon S; Dallan LAP; Tashtish N; Attizzani GF; Rashid I; Rajagopalan S; Arruda M; Filby SJ
    Catheter Cardiovasc Interv; 2024 Jan; 103(1):129-136. PubMed ID: 37786977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic review on left atrial appendage closure with the LAmbre device in patients with non-valvular atrial fibrillation.
    Ali M; Rigopoulos AG; Mammadov M; Torky A; Auer A; Matiakis M; Abate E; Bakogiannis C; Tzikas S; Bigalke B; Sedding D; Noutsias M
    BMC Cardiovasc Disord; 2020 Feb; 20(1):78. PubMed ID: 32050904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined atrial fibrillation ablation and left atrial appendage closure: long-term follow-up from a large multicentre registry.
    Wintgens L; Romanov A; Phillips K; Ballesteros G; Swaans M; Folkeringa R; Garcia-Bolao I; Pokushalov E; Boersma L
    Europace; 2018 Nov; 20(11):1783-1789. PubMed ID: 29547906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Feasibility and perioperative safety of the combined procedure of catheter ablation and watchman left atrial appendage closure].
    Wang QS; Chen M; Sun J; Zhang PP; Li W; Mo BF; Yu Y; Feng XF; Lu QF; Li YG
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Oct; 48(10):842-847. PubMed ID: 33076621
    [No Abstract]   [Full Text] [Related]  

  • 16. Percutaneous left atrial appendage closure for stroke prevention in patients with chronic renal disease.
    Lind A; Azizy O; Lortz J; Janosi A; Rassaf T; Rammos C
    Arch Med Sci; 2023; 19(2):331-336. PubMed ID: 37034526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experience of Combined Procedure during Percutaneous LAA Closure.
    Domain G; Dognin N; O'Hara G; Rodès-Cabau J; Paradis JM; Strubé C; Bernier M; O'Connor K; Beaudoin J; Philippon F; Salaun E; Champagne J
    J Clin Med; 2022 Jun; 11(12):. PubMed ID: 35743351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-Term Efficacy and Safety of Left Atrial Appendage Closure Procedures.
    Zadori A; Kis Z; Toth T; Szigeti M; Temesvari A; Fontos G; Nyolczas N; Andreka P
    Int Heart J; 2023 Mar; 64(2):188-195. PubMed ID: 36927928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First results of the Brazilian Registry of Percutaneous Left Atrial Appendage Closure.
    Guérios ÊE; Chamié F; Montenegro M; Saad EB; Brito FS; Caramori PA; Simões LC; Oliveira FRA; Giuliano LC; Tavares CMDF
    Arq Bras Cardiol; 2017 Nov; 109(5):440-447. PubMed ID: 29069203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cryoballoon pulmonary vein ablation and left atrial appendage closure combined procedure: A long-term follow-up analysis.
    Fassini G; Gasperetti A; Italiano G; Riva S; Moltrasio M; Dello Russo A; Casella M; Maltagliati A; Tundo F; Majocchi B; Arioli L; Al-Mohani G; Pontone G; Pepi M; Tondo C
    Heart Rhythm; 2019 Sep; 16(9):1320-1326. PubMed ID: 30928784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.